BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2194230)

  • 41. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conjugal transfer of imipenem resistance in Bacteroides fragilis.
    Bandoh K; Watanabe K; Muto Y; Tanaka Y; Kato N; Ueno K
    J Antibiot (Tokyo); 1992 Apr; 45(4):542-7. PubMed ID: 1592686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The occurrence of antibiotic resistance genes in drug resistant Bacteroides fragilis isolates from Groote Schuur Hospital, South Africa.
    Meggersee R; Abratt V
    Anaerobe; 2015 Apr; 32():1-6. PubMed ID: 25460195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
    Dijkmans BA; Vaishnav J; Mattie H
    J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleotide sequence analysis of Tn4551: use of ermFS operon fusions to detect promoter activity in Bacteroides fragilis.
    Smith CJ
    J Bacteriol; 1987 Oct; 169(10):4589-96. PubMed ID: 2820936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.
    McLafferty MA; Koch RL; Goldman P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):131-4. PubMed ID: 7081970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial expression levels of nimA are decisive for protection against metronidazole in Bacteroides fragilis.
    Kupc M; Paunkov A; Strasser D; Sóki J; Leitsch D
    Anaerobe; 2022 Oct; 77():102630. PubMed ID: 36028117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.
    Alauzet C; Berger S; Jean-Pierre H; Dubreuil L; Jumas-Bilak E; Lozniewski A; Marchandin H
    J Antimicrob Chemother; 2017 Sep; 72(9):2673-2675. PubMed ID: 28535278
    [No Abstract]   [Full Text] [Related]  

  • 50. Lactate dehydrogenase activity in Bacteroides fragilis group strains with induced resistance to metronidazole.
    Presečki Stanko A; Sóki J; Varda Brkić D; Plečko V
    J Glob Antimicrob Resist; 2016 Jun; 5():11-4. PubMed ID: 27436459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmid analysis of clinical isolates of Bacteroides fragilis group strains.
    Nagy E; Dányi E; Földes J
    Acta Microbiol Hung; 1990; 37(4):367-73. PubMed ID: 2099083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA repair in Escherichia coli: identification of the uvrD gene product.
    Maples VF; Kushner SR
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5616-20. PubMed ID: 6291053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains.
    Sóki J; Gal M; Brazier JS; Rotimi VO; Urbán E; Nagy E; Duerden BI
    J Antimicrob Chemother; 2006 Feb; 57(2):212-20. PubMed ID: 16338949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Potential vectors for molecular cloning in Brevibacterium flavum].
    Tolmachev OE; Gusiatiner MM
    Mol Gen Mikrobiol Virusol; 1991 Nov; (11):3-8. PubMed ID: 1808511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tn4400, a compound transposon isolated from Bacteroides fragilis, functions in Escherichia coli.
    Robillard NJ; Tally FP; Malamy MH
    J Bacteriol; 1985 Dec; 164(3):1248-55. PubMed ID: 2999075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transposon mutagenesis of the anaerobic commensal, Bacteroides fragilis, using the EZ::TN5 transposome.
    Veeranagouda Y; Husain F; Wexler HM
    FEMS Microbiol Lett; 2012 Aug; 333(2):94-100. PubMed ID: 22639975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of Bacteroides fragilis RecQ DNA helicases in cell survival after metronidazole exposure.
    Paul L; Patrick S; Nord CE; Abratt V
    FEMS Microbiol Lett; 2011 Jun; 319(2):125-32. PubMed ID: 21426382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.